Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer– A Brief Report From the CROWN Study

JTO Clinical and Research Reports(2024)

引用 0|浏览5
暂无评分
关键词
Anaplastic lymphoma kinase,Japan,lorlatinib,non-small cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要